Introduction Barrett’s oesophagus represents a well-established precursor to oesophageal adenocarcinoma, with progression from intestinal metaplasia to dysplasia and invasive cancer. Given the poor prognosis of advanced disease, early detection through surveillance endoscopy remains critical.
Introduction
Barrett’s oesophagus represents a well-established precursor to oesophageal adenocarcinoma, with progression from intestinal metaplasia to dysplasia and invasive cancer. Given the poor prognosis of advanced disease, early detection through surveillance endoscopy remains critical. Conventional surveillance relies on high-definition white light endoscopy combined with the Seattle protocol of random biopsies, which is labour-intensive and prone to sampling error. Emerging advanced imaging modalities, particularly narrow band imaging (NBI) and acetic acid chromoendoscopy (AAC), aim to enhance dysplasia detection and enable more targeted biopsy strategies.
Problem Statement
Despite technological advances, current surveillance strategies remain inefficient, with random biopsies risking missed dysplasia and increasing procedural burden. The key challenge is whether advanced imaging techniques can reliably replace or reduce reliance on the Seattle protocol while maintaining diagnostic safety.
Summary
This systematic review of 44 studies demonstrates that NBI-guided biopsies improve overall dysplasia detection compared with white light endoscopy, while AAC offers higher sensitivity for neoplasia detection and reduces biopsy burden. However, neither technique alone is sufficient to replace the Seattle protocol due to the risk of missed lesions.
The findings support a hybrid approach, integrating advanced imaging with systematic biopsies, while emphasising the need for high-quality randomised trials to define cost-effectiveness and optimise surveillance strategies in Barrett’s oesophagus.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.